GlassScriptPhysician profile
James W Ogilvie
NPI 1467409029
$12,763.65
in general payments reported to CMS, 2019-2025
12 companies · $37.63 in 2025
The $37.63 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,225 · 2020: $527 · 2021: $231 · 2022: $127 · 2023: $8,527 · 2024: $88.98 · 2025: $37.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,680 · Travel and Lodging: $682 · Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,680.00 |
| Travel and Lodging | $682.14 |
| Food and Beverage | $291.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Biotech Incorporated | $8,527.32 | 2023 | Biodesign, Oasis |
| Cook Incorporated | $3,200.00 | 2019 | |
| Cook Medical LLC | $526.56 | 2020 | |
| Si-Bone, INC. | $139.68 | 2021 | |
| Medtronic, INC. | $127.46 | 2022 | |
| Heron Therapeutics, INC. | $77.51 | 2021 | |
| Conmed Corporation | $51.48 | 2024 | Airseal |
| Aroa Biosurgery Incorporated | $37.63 | 2025 | |
| Ethicon US, LLC | $37.50 | 2024 | Monocryl |
| Edwards Lifesciences Corporation | $24.83 | 2019 | |
| Olympus America INC. | $13.68 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ogilvie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.